Fig. 3From: Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case reportAssessment of response by imaging, Computerized tomography and Magnetic resonance imaging, demonstrating stable disease according to RECIST v1.1 criteria—January 2023Back to article page